{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:03:48Z","timestamp":1790798628821,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CM23\/00037"],"award-info":[{"award-number":["CM23\/00037"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PMP22\/00092"],"award-info":[{"award-number":["PMP22\/00092"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI19\/01043"],"award-info":[{"award-number":["PI19\/01043"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["PMP22\/00092"],"award-info":[{"award-number":["PMP22\/00092"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.arbres.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:34:04Z","timestamp":1790368444000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional and Compositional Shifts in Lung and Gut Microbiota after One Year of Treatment with Highly Effective CFTR Modulators in Cystic Fibrosis"],"prefix":"10.1016","author":[{"given":"Natalia","family":"Bast\u00f3n-Paz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garc\u00eda-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do\u011dukan","family":"Bayraktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Moreno-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janetta","family":"Top","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"M\u00e1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saioa","family":"Vicente-Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Oteo-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Cant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concha","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C.","family":"Sch\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"de Dios Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.arbres.2026.08.007_bib0155","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.arbres.2026.08.007_bib0160","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.3390\/ijms21165882","article-title":"From ivacaftor to triple combination: a systematic review of efficacy and safety of CFTR modulators in people with cystic fibrosis","volume":"21","author":"Gramegna","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.arbres.2026.08.007_bib0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut microbiota in children with cystic fibrosis: a taxonomic and functional dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.arbres.2026.08.007_bib0170","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00832-2017","article-title":"Airway microbiota across age and disease spectrum in cystic fibrosis","volume":"50","author":"Zemanick","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.08.007_bib0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-0716-1936-0_5","article-title":"Sample processing for metaproteomic analysis of human gut microbiota","volume":"2420","author":"Garc\u00eda-Dur\u00e1n","year":"2022","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.arbres.2026.08.007_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108331","article-title":"Exploring the complexities of intestinal and pulmonary microbiota in cystic fibrosis: a multi-omics approach","volume":"248","author":"Bast\u00f3n-Paz","year":"2025","journal-title":"Respir Med"},{"issue":"19","key":"10.1016\/j.arbres.2026.08.007_bib0185","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"155","key":"10.1016\/j.arbres.2026.08.007_bib0190","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0112-2019","article-title":"Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease","volume":"29","author":"Shteinberg","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.arbres.2026.08.007_bib0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000538606","article-title":"Improved nutritional outcomes and gastrointestinal symptoms in adult cystic fibrosis patients treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"42","author":"Stastna","year":"2024","journal-title":"Dig Dis"},{"issue":"6","key":"10.1016\/j.arbres.2026.08.007_bib0200","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jcf.2025.09.004","article-title":"Real-world pancreatic function recovery and fluctuation in young children with cystic fibrosis on elexacaftor\/tezacaftor\/ivacaftor","volume":"24","author":"Schembri","year":"2025","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2026.08.007_bib0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clnesp.2023.08.028","article-title":"Effect of 18 months elexacaftor\u2013tezacaftor\u2013ivacaftor on body mass index and glycemic control in adults with cystic fibrosis","volume":"58","author":"Taelman","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.arbres.2026.08.007_bib0210","doi-asserted-by":"crossref","first-page":"1176815","DOI":"10.3389\/fphar.2023.1176815","article-title":"Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis","volume":"14","author":"Olivier","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.arbres.2026.08.007_bib0215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jcf.2023.01.007","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on liver tests at a large single adult cystic fibrosis centre","volume":"22","author":"Tewkesbury","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.arbres.2026.08.007_bib0220","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00519-24","article-title":"Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis","volume":"15","author":"Armbruster","year":"2024","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.arbres.2026.08.007_bib0225","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00787-24","article-title":"Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"12","author":"Hilliam","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.arbres.2026.08.007_bib0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12890-015-0062-7","article-title":"Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients","volume":"15","author":"Ahlgren","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.arbres.2026.08.007_bib0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcf.2023.05.003","article-title":"Eradication of nontuberculous Mycobacteria in people with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor: a multicenter cohort study","volume":"23","author":"Wiesel","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2026.08.007_bib0240","article-title":"Changes in intestinal microbiota in pediatric cystic fibrosis patients after 6 months of elexacaftor\u2013tezacaftor\u2013ivacaftor therapy","volume":"8","author":"Guti\u00e9rrez-D\u00edaz","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.arbres.2026.08.007_bib0245","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01935-23","article-title":"Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor\u2013tezacaftor\u2013ivacaftor","volume":"15","author":"Reasoner","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.arbres.2026.08.007_bib0250","doi-asserted-by":"crossref","first-page":"1103836","DOI":"10.3389\/fmicb.2022.1103836","article-title":"Butyrate producers, \u201cthe sentinel of gut\u201d: their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics","volume":"13","author":"Singh","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.arbres.2026.08.007_bib0255","doi-asserted-by":"crossref","first-page":"22493","DOI":"10.1038\/srep22493","article-title":"Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis","volume":"6","author":"Manor","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.arbres.2026.08.007_bib0260","doi-asserted-by":"crossref","first-page":"110231","DOI":"10.1016\/j.cbi.2022.110231","article-title":"Short chain fatty acids: fundamental mediators of the gut\u2013lung axis and their involvement in pulmonary diseases","volume":"368","author":"Ashique","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"6","key":"10.1016\/j.arbres.2026.08.007_bib0265","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jcf.2021.11.003","article-title":"A restructuring of microbiome niche space is associated with elexacaftor\u2013tezacaftor\u2013ivacaftor therapy in the cystic fibrosis lung","volume":"21","author":"Sosinski","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.arbres.2026.08.007_bib0270","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jcf.2024.10.001","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on the oropharyngeal metagenome in adolescents with cystic fibrosis","volume":"24","author":"Steinberg","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.arbres.2026.08.007_bib0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000031","article-title":"Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes","volume":"1","author":"Nagaev","year":"2006","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.arbres.2026.08.007_bib0280","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101870R","article-title":"Human intelectin-2 (ITLN2) is selectively expressed by secretory Paneth cells","volume":"36","author":"Nonnecke","year":"2022","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.arbres.2026.08.007_bib0285","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/thorax-2024-222242","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on systemic inflammation in cystic fibrosis","volume":"80","author":"Maher","year":"2025","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.arbres.2026.08.007_bib0290","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/microorganisms10020220","article-title":"Unravelling formaldehyde metabolism in bacteria: road towards synthetic methylotrophy","volume":"10","author":"Klein","year":"2022","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.arbres.2026.08.007_bib0295","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","article-title":"A faecal microbiota signature with high specificity for pancreatic cancer","volume":"71","author":"Kartal","year":"2022","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.arbres.2026.08.007_bib0300","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2025.05.006","article-title":"Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor\/tezacaftor\/ivacaftor: findings from the promise study","volume":"24","author":"Duong","year":"2025","journal-title":"J Cyst Fibros"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626003182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626003182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:50:15Z","timestamp":1790797815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289626003182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0300289626003182"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2026.08.007","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional and Compositional Shifts in Lung and Gut Microbiota after One Year of Treatment with Highly Effective CFTR Modulators in Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}